{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T11:06:07Z","timestamp":1784459167307,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,26]]},"DOI":"10.7759\/cureus.59104","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T02:29:17Z","timestamp":1714184957000},"source":"Crossref","is-referenced-by-count":7,"title":["Advances in Understanding and Managing Myasthenia Gravis: Current Trends and Future Directions"],"prefix":"10.7759","author":[{"given":"Shreya","family":"Jaiswal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tripti","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus NE","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015, 14:1023-36. 10.1016\/S1474-4422(15)00145-3","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2023.04.006","article-title":"Myasthenia gravis. Update on diagnosis and therapy","volume":"161","author":"Garc\u00eda Est\u00e9vez DA","year":"2023","unstructured":"Garc\u00eda Est\u00e9vez DA, Pardo Fern\u00e1ndez J. Myasthenia gravis. Update on diagnosis and therapy. Med Clin (Barc). 2023, 161:119-27. 10.1016\/j.medcli.2023.04.006","journal-title":"Med Clin (Barc)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.01.002","article-title":"Generalized Myasthenia Gravis: classification, clinical presentation, natural history, and epidemiology","volume":"36","author":"Hehir MK","year":"2018","unstructured":"Hehir MK, Silvestri NJ. Generalized Myasthenia Gravis: classification, clinical presentation, natural history, and epidemiology. Neurol Clin. 2018, 36:253-60. 10.1016\/j.ncl.2018.01.002","journal-title":"Neurol Clin"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2014.01.003","article-title":"Diagnostic and clinical classification of autoimmune myasthenia gravis","volume":"48-49","author":"Berrih-Aknin S","year":"2014","unstructured":"Berrih-Aknin S, Frenkian-Cuvelier M, Eymard B. Diagnostic and clinical classification of autoimmune myasthenia gravis. J Autoimmun. 2014, 48-49:143-8. 10.1016\/j.jaut.2014.01.003","journal-title":"J Autoimmun"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis","volume":"52","author":"Zisimopoulou P","year":"2014","unstructured":"Zisimopoulou P, Evangelakou P, Tzartos J, et al.. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis. J Autoimmun. 2014, 52:139-45. 10.1016\/j.jaut.2013.12.004","journal-title":"J Autoimmun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/09638288.2013.804591","article-title":"Development of the MG-DIS: an ICF-based disability assessment instrument for myasthenia gravis","volume":"36","author":"Raggi A","year":"2014","unstructured":"Raggi A, Schiavolin S, Leonardi M, Antozzi C, Baggi F, Maggi L, Mantegazza R. Development of the MG-DIS: an ICF-based disability assessment instrument for myasthenia gravis. Disabil Rehabil. 2014, 36:546-55. 10.3109\/09638288.2013.804591","journal-title":"Disabil Rehabil"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2020.09.007","article-title":"Update in the management of myasthenia gravis and Lambert-Eaton myasthenic syndrome","volume":"39","author":"Bodkin C","year":"2021","unstructured":"Bodkin C, Pascuzzi RM. Update in the management of myasthenia gravis and Lambert-Eaton myasthenic syndrome. Neurol Clin. 2021, 39:133-46. 10.1016\/j.ncl.2020.09.007","journal-title":"Neurol Clin"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-0968.2002.00403.x","article-title":"Myasthenia gravis and Lambert-Eaton syndrome","volume":"6","author":"Pascuzzi RM","year":"2002","unstructured":"Pascuzzi RM. Myasthenia gravis and Lambert-Eaton syndrome. Ther Apher. 2002, 6:57-68. 10.1046\/j.1526-0968.2002.00403.x","journal-title":"Ther Apher"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/BF03007987","article-title":"Prediction of the need for postoperative mechanical ventilation in myasthenia gravis: thymectomy compared to other surgical procedures","volume":"29","author":"Grant RP","year":"1982","unstructured":"Grant RP, Jenkins LC. Prediction of the need for postoperative mechanical ventilation in myasthenia gravis: thymectomy compared to other surgical procedures. Can Anaesth Soc J. 1982, 29:112-6. 10.1007\/BF03007987","journal-title":"Can Anaesth Soc J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13537","article-title":"Developing treatment guidelines for myasthenia gravis","volume":"1412","author":"Sanders DB","year":"2018","unstructured":"Sanders DB, Wolfe GI, Narayanaswami P. Developing treatment guidelines for myasthenia gravis. Ann N Y Acad Sci. 2018, 1412:95-101. 10.1111\/nyas.13537","journal-title":"Ann N Y Acad Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.90a.22017","article-title":"Myasthenia gravis: frequently asked questions","volume":"90","author":"Morren JA","year":"2023","unstructured":"Morren JA, Li Y. Myasthenia gravis: frequently asked questions. Cleve Clin J Med. 2023, 90:103-13. 10.3949\/ccjm.90a.22017","journal-title":"Cleve Clin J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1558975","article-title":"Myasthenia gravis","volume":"35","author":"Gwathmey KG","year":"2015","unstructured":"Gwathmey KG, Burns TM. Myasthenia gravis. Semin Neurol. 2015, 35:327-39. 10.1055\/s-0035-1558975","journal-title":"Semin Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9138548","article-title":"Tacrolimus as single-agent immunotherapy and minimal manifestation status in nonthymoma myasthenia gravis","volume":"2021","author":"Duan W","year":"2021","unstructured":"Duan W, Peng Y, Jin W, Ouyang S, Yang H. Tacrolimus as single-agent immunotherapy and minimal manifestation status in nonthymoma myasthenia gravis. J Immunol Res. 2021, 2021:9138548. 10.1155\/2021\/9138548","journal-title":"J Immunol Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000800","article-title":"Myasthenia gravis and congenital myasthenic syndromes","volume":"25","author":"Ciafaloni E","year":"2019","unstructured":"Ciafaloni E. Myasthenia gravis and congenital myasthenic syndromes. Continuum (Minneap Minn). 2019, 25:1767-84. 10.1212\/CON.0000000000000800","journal-title":"Continuum (Minneap Minn)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): A phase 3, randomised, double-blind, placebo-controlled, multicentre study","volume":"16","author":"Howard JF","year":"2017","unstructured":"Howard JF, Utsugisawa K, Benatar M, et al.. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): A phase 3, randomised, double-blind, placebo-controlled, multicentre study. Lancet Neurol. 2017, 16:976-86. 10.1016\/S1474-4422(17)30369-1","journal-title":"Lancet Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25973","article-title":"B cells in the pathophysiology of myasthenia gravis","volume":"57","author":"Yi JS","year":"2018","unstructured":"Yi JS, Guptill JT, Stathopoulos P, Nowak RJ, O'Connor KC. B cells in the pathophysiology of myasthenia gravis. Muscle Nerve. 2018, 57:172-84. 10.1002\/mus.25973","journal-title":"Muscle Nerve"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis - autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus NE","year":"2016","unstructured":"Gilhus NE, Skeie GO, Romi F, Lazaridis K, Zisimopoulou P, Tzartos S. Myasthenia gravis - autoantibody characteristics and their implications for therapy. Nat Rev Neurol. 2016, 12:259-68. 10.1038\/nrneurol.2016.44","journal-title":"Nat Rev Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2013.09.012","article-title":"[Myasthenia gravis and autoantibodies: pathophysiology of the different subtypes]","volume":"35","author":"Berrih-Aknin S","year":"2014","unstructured":"Berrih-Aknin S, Le Panse R. [Myasthenia gravis and autoantibodies: pathophysiology of the different subtypes]. Rev Med Interne. 2014, 35:413-20. 10.1016\/j.revmed.2013.09.012","journal-title":"Rev Med Interne"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2017.06.009","article-title":"Myasthenia gravis and crisis: evaluation and management in the emergency department","volume":"53","author":"Roper J","year":"2017","unstructured":"Roper J, Fleming ME, Long B, Koyfman A. Myasthenia gravis and crisis: evaluation and management in the emergency department. J Emerg Med. 2017, 53:843-53. 10.1016\/j.jemermed.2017.06.009","journal-title":"J Emerg Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000473","article-title":"Myasthenia gravis: new developments in research and treatment","volume":"30","author":"Evoli A","year":"2017","unstructured":"Evoli A. Myasthenia gravis: new developments in research and treatment. Curr Opin Neurol. 2017, 30:464-70. 10.1097\/WCO.0000000000000473","journal-title":"Curr Opin Neurol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000001161","article-title":"Diagnosis and management of myasthenia gravis","volume":"28","author":"Hehir MK 2nd","year":"2022","unstructured":"Hehir MK 2nd, Li Y. Diagnosis and management of myasthenia gravis. Continuum (Minneap Minn). 2022, 28:1615-42. 10.1212\/CON.0000000000001161","journal-title":"Continuum (Minneap Minn)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.semerg.2018.01.003","article-title":"[An update on myasthenia gravis]","volume":"44","author":"Mart\u00ednez Torre S","year":"2018","unstructured":"Mart\u00ednez Torre S, G\u00f3mez Molinero I, Mart\u00ednez Gir\u00f3n R. [An update on myasthenia gravis]. Semergen. 2018, 44:351-4. 10.1016\/j.semerg.2018.01.003","journal-title":"Semergen"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.715036","article-title":"Clinical efficacy and safety of eculizumab for treating myasthenia gravis","volume":"12","author":"Xiao H","year":"2021","unstructured":"Xiao H, Wu K, Liang X, Li R, Lai KP. Clinical efficacy and safety of eculizumab for treating myasthenia gravis. Front Immunol. 2021, 12:715036. 10.3389\/fimmu.2021.715036","journal-title":"Front Immunol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1080\/08164622.2022.2029683","article-title":"Ocular myasthenia gravis: a review and practical guide for clinicians","volume":"105","author":"Shuey NH","year":"2022","unstructured":"Shuey NH. Ocular myasthenia gravis: a review and practical guide for clinicians. Clin Exp Optom. 2022, 105:205-13. 10.1080\/08164622.2022.2029683","journal-title":"Clin Exp Optom"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2018.1491310","article-title":"Advances in autoimmune myasthenia gravis management","volume":"18","author":"Wang S","year":"2018","unstructured":"Wang S, Breskovska I, Gandhy S, Punga AR, Guptill JT, Kaminski HJ. Advances in autoimmune myasthenia gravis management. Expert Rev Neurother. 2018, 18:573-88. 10.1080\/14737175.2018.1491310","journal-title":"Expert Rev Neurother"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1254.060","article-title":"Treatment principles in the management of autoimmune myasthenia gravis","volume":"998","author":"Richman DP","year":"2003","unstructured":"Richman DP, Agius MA. Treatment principles in the management of autoimmune myasthenia gravis. Ann N Y Acad Sci. 2003, 998:457-72. 10.1196\/annals.1254.060","journal-title":"Ann N Y Acad Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/s0887-8994(99)00112-5","article-title":"High-dose intravenous immunoglobulin therapy in juvenile myasthenia gravis","volume":"22","author":"Selcen D","year":"2000","unstructured":"Selcen D, Dabrowski ER, Michon AM, Nigro MA. High-dose intravenous immunoglobulin therapy in juvenile myasthenia gravis. Pediatr Neurol. 2000, 22:40-3. 10.1016\/s0887-8994(99)00112-5","journal-title":"Pediatr Neurol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.1.108","article-title":"Myasthenia gravis presenting with stridor","volume":"51","author":"Hanson JA","year":"1996","unstructured":"Hanson JA, Lueck CJ, Thomas DJ. Myasthenia gravis presenting with stridor. Thorax. 1996, 51:108-9. 10.1136\/thx.51.1.108","journal-title":"Thorax"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-207708","article-title":"Anti-MuSK-positive myasthenia gravis diagnosed during pregnancy: new challenges for an old disease?","volume":"2015","author":"Neves AR","year":"2015","unstructured":"Neves AR, Monteiro P, Matos A, Santos Silva I. Anti-MuSK-positive myasthenia gravis diagnosed during pregnancy: new challenges for an old disease?. BMJ Case Rep. 2015, 2015:bcr2014207708. 10.1136\/bcr-2014-207708","journal-title":"BMJ Case Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/00005768-200012000-00001","article-title":"Myasthenia gravis in a collegiate football player","volume":"32","author":"Leddy JJ","year":"2000","unstructured":"Leddy JJ, Chutkow JG. Myasthenia gravis in a collegiate football player. Med Sci Sports Exerc. 2000, 32:1975-9. 10.1097\/00005768-200012000-00001","journal-title":"Med Sci Sports Exerc"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1053\/j.semtcvs.2012.06.003","article-title":"Unilateral extended thoracoscopic thymectomy for nontumoral myasthenia gravis\u2014a new standard","volume":"24","author":"Tomulescu V","year":"2012","unstructured":"Tomulescu V, Popescu I. Unilateral extended thoracoscopic thymectomy for nontumoral myasthenia gravis\u2014a new standard. Semin Thorac Cardiovasc Surg. 2012, 24:115-22. 10.1053\/j.semtcvs.2012.06.003","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0b013e3181823d11","article-title":"Obstetric and anesthetic management of severe congenital myasthenia syndrome","volume":"107","author":"Terblanche N","year":"2008","unstructured":"Terblanche N, Maxwell C, Keunen J, Carvalho JC. Obstetric and anesthetic management of severe congenital myasthenia syndrome. Anesth Analg. 2008, 107:1313-5. 10.1213\/ane.0b013e3181823d11","journal-title":"Anesth Analg"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103313","article-title":"Microbiota dysbiosis and myasthenia gravis: do all roads lead to Rome?","volume":"22","author":"Kapoor B","year":"2023","unstructured":"Kapoor B, Gulati M, Gupta R, Singla RK. Microbiota dysbiosis and myasthenia gravis: do all roads lead to Rome?. Autoimmun Rev. 2023, 22:103313. 10.1016\/j.autrev.2023.103313","journal-title":"Autoimmun Rev"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000682","article-title":"Critical care of neuromuscular disorders","volume":"24","author":"Greene-Chandos D","year":"2018","unstructured":"Greene-Chandos D, Torbey M. Critical care of neuromuscular disorders. Continuum (Minneap Minn). 2018, 24:1753-75. 10.1212\/CON.0000000000000682","journal-title":"Continuum (Minneap Minn)"},{"key":"ref35","article-title":"[Desflurane anesthesia without muscle relaxant for a patient with myasthenia gravis undergoing laparoscopic high anterior resection: a case report]","volume":"5","author":"Koda K","year":"2008","unstructured":"Koda K, Kimura H, Uzawa M, Sambe N, Sugano T, Kitamura T, Tagami M. [Desflurane anesthesia without muscle relaxant for a patient with myasthenia gravis undergoing laparoscopic high anterior resection: a case report]. Neurotherapeutics. 2008, 5:535-41.","journal-title":"Neurotherapeutics"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2021.09.013","article-title":"Effectiveness of thymectomy in juvenile myasthenia gravis and clinical characteristics associated with better outcomes","volume":"31","author":"Ng WC","year":"2021","unstructured":"Ng WC, Hartley L. Effectiveness of thymectomy in juvenile myasthenia gravis and clinical characteristics associated with better outcomes. Neuromuscul Disord. 2021, 31:1113-23. 10.1016\/j.nmd.2021.09.013","journal-title":"Neuromuscul Disord"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2016.01.006","article-title":"Evidence for thymectomy in myasthenia gravis: getting stronger?","volume":"154","author":"de Perrot M","year":"2017","unstructured":"de Perrot M, McRae K. Evidence for thymectomy in myasthenia gravis: getting stronger?. J Thorac Cardiovasc Surg. 2017, 154:314-6. 10.1016\/j.jtcvs.2016.01.006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1177\/0218492318759348","article-title":"Video-assisted thoracoscopic thymectomy for thymoma: a single-center experience","volume":"26","author":"Nguyen GT","year":"2018","unstructured":"Nguyen GT, Nguyen TN, Nguyen NV, Nguyen KT, Le AV. Video-assisted thoracoscopic thymectomy for thymoma: a single-center experience. Asian Cardiovasc Thorac Ann. 2018, 26:207-11. 10.1177\/0218492318759348","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21185","article-title":"Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite","volume":"38","author":"Burns TM","year":"2008","unstructured":"Burns TM, Conaway MR, Cutter GR, Sanders DB. Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite. Muscle Nerve. 2008, 38:1553-62. 10.1002\/mus.21185","journal-title":"Muscle Nerve"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-014-1659-y","article-title":"Predictors of outcome of myasthenic crisis","volume":"35","author":"Kalita J","year":"2014","unstructured":"Kalita J, Kohat AK, Misra UK. Predictors of outcome of myasthenic crisis. Neurol Sci. 2014, 35:1109-14. 10.1007\/s10072-014-1659-y","journal-title":"Neurol Sci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cryobiol.2013.06.008","article-title":"Combination percutaneous cryotherapy and iodine-125 seed implantation for unresectable malignant thymoma: experience in 19 patients","volume":"67","author":"Zhang Z","year":"2013","unstructured":"Zhang Z, Wu B, Niu L, et al.. Combination percutaneous cryotherapy and iodine-125 seed implantation for unresectable malignant thymoma: experience in 19 patients. Cryobiology. 2013, 67:170-4. 10.1016\/j.cryobiol.2013.06.008","journal-title":"Cryobiology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/205045-advances-in-understanding-and-managing-myasthenia-gravis-current-trends-and-future-directions","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T02:29:22Z","timestamp":1714184962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/205045-advances-in-understanding-and-managing-myasthenia-gravis-current-trends-and-future-directions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":41,"URL":"https:\/\/doi.org\/10.7759\/cureus.59104","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,26]]}}}